Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease

Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disorder that attacks the nerves and can eventually paralyze the entire body. The biomarker, neurofilament light chain, or NfL, signals the presence of axonal damage. As published in the Journal of Neurology, Neurosurgery, and Psychiatry, high circulating levels of NfL in GBS…

--

--

--

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

A Medical Emergency

https://www.youtube.com/watch?v=Dji6xbCYK3I

#Radiating Real #40 — About Hard Decisions in a COVID World. 🤔

TrustUS: disrupting the 30-billion fertility industry with FinTech

Number and Percentage of Embryo Transfers That Used a Gestational Carrier — United States, 2010–2019

5 Common Myths about Patient Engagement Debunked

Vaccines Reduce Transmission

Finally…It’s Diabetes Awareness Day!!!

MygenoMD Is Making Genetic Health Data Accessible and Actionable

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

Violet Extract Boosts Brain Cancer Drug’s Performance

Study Showed How To Break The Vicious Anorexia-Sarcopenia Cycle Of Ageing.

The Implications Of Clotting In A Heart Attack

Temporomandibular Joint (TMJ) Dysfunction and Foundational Correction